Presentation is loading. Please wait.

Presentation is loading. Please wait.

Somatic Mutation Distributions Determining Cut-offs Supp. Figure 5.

Published byKaiya Axe Modified over 9 years ago

Similar presentations

Presentation on theme: "Somatic Mutation Distributions Determining Cut-offs Supp. Figure 5."— Presentation transcript:

1 Somatic Mutation Distributions Determining Cut-offs Supp. Figure 5

2 Cancer Type Mutated Genes Cutoff BRCA, Breast Carcinoma & Breast Cancer147 COAD, COADREAD & Colorectal Cancer227 GBM & Glioblastoma Multiforme164 LUAD & Lung Adenocarcinoma26 LAML36 Myeloproliferative Disorders10 Chronic Lymphocytic Leukemia38 HNSC360 KIRC150 KIRP173 LGG110 OV167 Pancreatic Cancer70 STAD357 THCA47 UCEC129 PRAD (Prostate Adenocarcinoma)118 Pediatric Brain Tumors30 Summary Table

3 Mutated Genes Cutoff

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

Download ppt "Somatic Mutation Distributions Determining Cut-offs Supp. Figure 5."

Similar presentations

Gene 210 Cancer Genomics May 5, 2015. Key events in investigating the cancer genome M R Stratton Science 2011;331:1553-1558.

Gene 210 Cancer Genomics May 5, Key events in investigating the cancer genome M R Stratton Science 2011;331:
P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.

P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.
Infrastructure for Sharing Very Large Data Sets Antonio M. Ferreira, PhD Executive Director, Center for Simulation and Modeling.

Infrastructure for Sharing Very Large Data Sets Antonio M. Ferreira, PhD Executive Director, Center for Simulation and Modeling.
Cancer. 2003 Estimated US Cancer Cases Cancer Incidence Rates for Women, USA.

Cancer Estimated US Cancer Cases Cancer Incidence Rates for Women, USA.
Introduction 30-40% of all cancers arise from the epithelial lining of the aerodigestive tract. 51% & 38% of cancer deaths of men and women are from lung.

Introduction 30-40% of all cancers arise from the epithelial lining of the aerodigestive tract. 51% & 38% of cancer deaths of men and women are from lung.
BRCA1 and BRCA2 are genes which normally help to prevent breast cancer by making proteins which inhibit abnormal cellular growth. While a woman with an.

BRCA1 and BRCA2 are genes which normally help to prevent breast cancer by making proteins which inhibit abnormal cellular growth. While a woman with an.
Most common cancers among MEN 1.Prostate (128.3) (15.6% death rate) 2.Lung (73) (79.3% death rate) 3.Colorectal (46.1) (39.3% death rate) Most Common Cancers.

Most common cancers among MEN 1.Prostate (128.3) (15.6% death rate) 2.Lung (73) (79.3% death rate) 3.Colorectal (46.1) (39.3% death rate) Most Common Cancers.
INCLUDE THE NAME OF YOUR TYPE OF CANCER! MAKE SURE YOU INCLUDE SEVERAL APPROPRIATE PICTURES IN YOUR POWERPOINT! ONLY POINT FORM IS ALLOWED ON SLIDES (NO.

INCLUDE THE NAME OF YOUR TYPE OF CANCER! MAKE SURE YOU INCLUDE SEVERAL APPROPRIATE PICTURES IN YOUR POWERPOINT! ONLY POINT FORM IS ALLOWED ON SLIDES (NO.
Supplementary Figure 2: Representative Kaplan-Meier plots of overall survival considering alterations erbB signaling pathway genes and p53 in lung cancer.

Supplementary Figure 2: Representative Kaplan-Meier plots of overall survival considering alterations erbB signaling pathway genes and p53 in lung cancer.
Cancer “whiteboard” presentation ●Name of cancer (what type), where can it occur? ●Function of body part that it affects ●Causes (genetic, environmental…)?

Cancer “whiteboard” presentation ●Name of cancer (what type), where can it occur? ●Function of body part that it affects ●Causes (genetic, environmental…)?
INTRODUCTION ▪ MPM(malignant pleural mesothelioma ) is an aggressive cancer arising from the mesothelial cells of the pleura. About 80% of mesothelioma.

INTRODUCTION ▪ MPM(malignant pleural mesothelioma ) is an aggressive cancer arising from the mesothelial cells of the pleura. About 80% of mesothelioma.
Brain Tumors 2.21.16 Mark Browning, M.D. IUSME. Differential Diagnosis includes: Primary CNS tumor Most common primary sites of brain mets: – Lung – Breast.

Brain Tumors Mark Browning, M.D. IUSME. Differential Diagnosis includes: Primary CNS tumor Most common primary sites of brain mets: – Lung – Breast.
In describing a person’s cancer what would T2 mean? In describing a person’s cancer what does M1 mean? In describing a person’s cancer what does N0 mean?

In describing a person’s cancer what would T2 mean? In describing a person’s cancer what does M1 mean? In describing a person’s cancer what does N0 mean?
Karli Has Cancer Group Discussion 1.In what ways is Karli different from you? 2.What does Karli mean when she says people “don’t understand that cancer.

Karli Has Cancer Group Discussion 1.In what ways is Karli different from you? 2.What does Karli mean when she says people “don’t understand that cancer.
PIK3CA gene amplification in glioblastoma and squamous cell carcinoma (SCC) of the lung. PIK3CA gene amplification in glioblastoma and squamous cell carcinoma.

PIK3CA gene amplification in glioblastoma and squamous cell carcinoma (SCC) of the lung. PIK3CA gene amplification in glioblastoma and squamous cell carcinoma.
Exercise 14-15/12/15. Install required packages R Packages & Data – Package Installer – Repository: CRAN / BioConductor Packages you need: – igraph (CRAN)

Exercise 14-15/12/15. Install required packages R Packages & Data – Package Installer – Repository: CRAN / BioConductor Packages you need: – igraph (CRAN)
Development of a Pan-Cancer 15 Gene Expression Signature to Detect a Subgroup Driven by MAPK Signalling Nuala McCabe,1,2 Laura A. Knight, 2 Andrena McCavigan,2.

Development of a Pan-Cancer 15 Gene Expression Signature to Detect a Subgroup Driven by MAPK Signalling Nuala McCabe,1,2 Laura A. Knight, 2 Andrena McCavigan,2.
Charles M. Rudin, MD, PhD, Alexander Drilon, MD, J.T. Poirier, PhD 

Charles M. Rudin, MD, PhD, Alexander Drilon, MD, J.T. Poirier, PhD 
Curate patient-centric multi-omics data for precision medicine

Curate patient-centric multi-omics data for precision medicine
Fostering a Collaborative Approach in the Management of BRCA-Mutated Ovarian Cancer.

Fostering a Collaborative Approach in the Management of BRCA-Mutated Ovarian Cancer.

Similar presentations

Ads by Google